Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | 3,250,000 | reported | 05 May 2011 | tx 1+250,000 |
| Inmune Bio, Inc. | 750,000 | reported | 01 Dec 2025 | tx 52+3,507,485−1,532,259 |
| MAPLE MOUNTAIN EXPLORATIONS INC. | 200,000 | reported | 01 Feb 2008 | tx 4+433,335 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Dec 2025 | GRANT_AWARD | Inmune Bio, Inc. | 750,000 | 0.00 USD | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 160,000 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 160,000 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 130,000 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 130,000 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 223,000 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 223,000 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 160,000 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 160,000 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 400,000 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 400,000 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 59,337 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 59,337 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 275,000 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 275,000 | — | deriv |
| 18 Nov 2025 | OTHER | Inmune Bio, Inc. | 70,663 | — | deriv |
| 18 Nov 2025 | GRANT_AWARD | Inmune Bio, Inc. | 70,663 | — | deriv |
| 05 Dec 2024 | GRANT_AWARD | Inmune Bio, Inc. | 223,000 | 0.00 USD | deriv |
| 30 Sept 2024 | PURCHASE | Inmune Bio, Inc. | 10,000 | 5.29 USD | |
| 12 Sept 2024 | PURCHASE | Inmune Bio, Inc. | 7,690 | 6.38 USD | |
| 12 Sept 2024 | PURCHASE | Inmune Bio, Inc. | 7,690 | 0.13 USD | deriv |
| 14 May 2024 | GRANT_AWARD | Inmune Bio, Inc. | 160,000 | 0.00 USD | deriv |
| 19 Apr 2024 | GRANT_AWARD | Inmune Bio, Inc. | 18,028 | 8.32 USD | |
| 19 Apr 2024 | GRANT_AWARD | Inmune Bio, Inc. | 18,028 | 0.13 USD | deriv |
| 17 Mar 2023 | PURCHASE | Inmune Bio, Inc. | 2,500 | 6.43 USD |
2 purchases reported after at least 12 months of silence — most recent on 26 May 2022.